During the past decade, Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Martin-Luther-Universität Halle-Wittenberg" with 2 trials sponsored, "University of Ulm" with 2 trials sponsored, "Aktion Bronchialkarzinom e.V." with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "National Center for Tumor Diseases, Heidelberg" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" in a lesser frequency.

Most popular intervention types in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Trastuzumab" (3 trials), "Capecitabine" (2 trials), "Pertuzumab" (2 trials) and "5-FU/LV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".